Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Retained Earnings (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Retained Earnings for 14 consecutive years, with -$80.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 9.33% year-over-year to -$80.0 million, compared with a TTM value of -$80.0 million through Dec 2025, down 9.33%, and an annual FY2025 reading of -$78.6 million, down 4.81% over the prior year.
  • Retained Earnings was -$80.0 million for Q4 2025 at Neuroone Medical Technologies, down from -$78.6 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$35.2 million in Q1 2021 and bottomed at -$80.0 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$60.1 million, with a median of -$61.1 million recorded in 2023.
  • The sharpest move saw Retained Earnings tumbled 32.88% in 2021, then dropped 4.81% in 2025.
  • Year by year, Retained Earnings stood at -$43.6 million in 2021, then fell by 20.45% to -$52.6 million in 2022, then fell by 25.63% to -$66.0 million in 2023, then dropped by 10.89% to -$73.2 million in 2024, then decreased by 9.33% to -$80.0 million in 2025.
  • Business Quant data shows Retained Earnings for NMTC at -$80.0 million in Q4 2025, -$78.6 million in Q3 2025, and -$77.0 million in Q2 2025.